English

Share Buyback in H. Lundbeck A/S

Report this content 

                        
During any one single trading day a maximum of 25% of the average
daily trading volume of Lundbeck shares on OMX Nordic Exchange
Copenhagen, calculated over 20 days prior to each trading date, will
be bought back, as the share buyback program is implemented in
accordance with the provisions of the European Commission's
regulation no. 2273/2003 of December 22, 2003.

At least once every seven trading days, Lundbeck will issue an
announcement in respect of the transactions made under the program.

The following transactions have been made under the program:


                       No. of shares        Average Transaction value
                                     purchase price             (DKK)
                                              (DKK)
Accumulated, last         27,840,262       135.1343     3,762,174,252
announcement
18 February 2008               8,300       116.8084 909,509.51
19 February 2008                  --             -- --
20 February 2008              70,500       117.9579 8,316,030.94
21 February 2008                  --             -- --
22 February 2008              63,700       117.0185 7,454,077.18
25 February 2008                  --             -- --
26 February 2008              57,000       117.5128 6,698,232.24
Accumulated under the     28,039,762       135.0087     3,785,612,102
program


Following the above buyback it is hereby announced that Lundbeck owns
a total of 8,882,975 own shares at a nominal value of DKK 5, equal to
4.29% of the total number of 207,279,631 shares.

The content of this release will have no influence on the Lundbeck
Group's financial results for the 2007 financial year, due to be
announced on 4 March 2008. On the same occasion, Lundbeck will
present its financial guidance for 2008.

Lundbeck contacts


Investors:                    Media:

Jacob Tolstrup                Anders Schroll
Director, Corporate Reporting Head of Communication
+45 36 43 30 79               +45 36 43 20 81

Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26


                      ________________________

Stock Exchange Release No 325 - 26 February 2008

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com




                                            

                

            

        

    

    



    

        
 Subscribe

        

            

        

    


        

            
        

        

            
        

        



    

        
 Documents & Links